Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 110.49 0.75 (0.68%) Market Cap: 6.97 Bil Enterprise Value: 10.88 Bil PE Ratio: 22.78 PB Ratio: 1.88 GF Score: 78/100

Jazz Pharmaceuticals PLC Investor Update at World Sleep Congress Transcript

Sep 26, 2019 / 01:00AM GMT
Release Date Price: $128.39 (-1.95%)
Operator

Welcome to the Jazz Pharmaceuticals plc Investor Update Conference Call. (Operator Instructions)

I will now turn the call over to Kathee Littrell, Head of Investor Relations at Jazz Pharmaceuticals.

Katherine A. Littrell
Jazz Pharmaceuticals plc - VP of IR

Thank you, Latif, and I want to thank you all for joining us for our investor update from the World Sleep Congress.

Before we begin the webcast, I will point out that we will be making forward-looking statements today, including statements regarding our study results, plans and expectations and other business updates for JZP-258 and Sunosi.

Our forward-looking statements are subject to risks and uncertainties described in our quarterly report on Form 10-Q for the quarter ended June 30, 2019, and our other filings with the Securities and Exchange Commission and actual events and results may differ materially. We understand no -- we undertake no duty or obligation to update any forward-looking statements we make today.

Finally, I'll remind you that we are not confirming

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot